ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

US FDA approves Novartis' gene therapy for rare muscle disorder
The US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular atrophy. Itvisma offers a new option for a broader patient group. The therapy aims to replace a faulty gene crucial for muscle functi
Announcement as on 25 November 2025

Novartis AG Basel Reaches Analyst Target Price
In recent trading, shares of Novartis AG Basel (Symbol: NVS) have crossed above the average analyst 12-month target price of 7.00, changing hands for 7.11/share. When a stock reaches the target an analyst has set, the analyst logically has two ways
Announcement as on 11 November 2025

Novartis To Acquire Avidity Biosciences In Bln Deal
(RTTNews) - Novartis AG (NVS, NOVN.SW) announced that it has entered into a definitive agreement to acquire Avidity Biosciences Inc. (RNA) for .00 per share in cash, valuing the company at approximately .0 billion on a fully diluted basis. The transa
Announcement as on 27 October 2025

In major move, patent of Novartis' blockbuster cardiac drug revoked by India
The Indian Patent Office revoked Novartis' patent for Vymada, a heart failure drug, citing a lack of novelty and inventive step. This decision paves the way for generic versions, potentially lowering treatment costs for Indian patients. Domestic pharmaceut
Announcement as on 16 September 2025

Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver
GLP-1 drugs are taking much oxygen out of the biotechnology trade. However, many investors have been eyeing other areas in the sector, particularly cancer research. Novartis AG (NYSE: NVS) is up over 31% in 2025, and a novel cancer treatment could giv
Announcement as on 09 September 2025

Announcements by Novartis first page | Next page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 788.06
  • 12Day Average: 791.3
  • 20Day Average: 787.22
  • 50Day Average: 798.98
  • 100Day Average: 843.36
  • 150Day Average: 896.21
  • 200Day Average: 892.87

500672 Indicators & signals

Indicator MACD (12,26,9)

787.24, 791.05, -3.59
Indicator MACD is in negative zone

Indicator ADX (14)

43.38, 10.64, 26.95
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
21 Wed Jan 2026 766.40 750.00 to 788.00 -1.81% 2.78 times
20 Tue Jan 2026 780.55 776.05 to 803.85 -2.42% 0.58 times
19 Mon Jan 2026 799.90 788.00 to 807.75 -0.23% 0.63 times
16 Fri Jan 2026 801.75 785.00 to 807.45 1.27% 0.56 times
14 Wed Jan 2026 791.70 775.00 to 797.95 0.71% 0.57 times
13 Tue Jan 2026 786.15 772.00 to 797.50 0.48% 0.6 times
12 Mon Jan 2026 782.40 764.35 to 807.10 -2.21% 0.98 times
09 Fri Jan 2026 800.05 800.00 to 808.00 -0.06% 1.16 times
08 Thu Jan 2026 800.55 798.00 to 804.60 -0.02% 0.94 times
07 Wed Jan 2026 800.75 800.00 to 808.80 -0.01% 1.36 times
06 Tue Jan 2026 800.85 780.10 to 810.40 2.08% 2.63 times
05 Mon Jan 2026 784.55 778.10 to 787.40 0.66% 1.18 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top